Pegylated recombinant human granulocyte-stimulating factor injection

1. When patients with non-myeloid malignancies are treated with bone marrow suppressive antineoplastic drugs that may cause clinically significant febrile neutropenia, the use of this product can reduce the incidence of infection caused by febrile neutropenia. 2. This product is not used to mobilize peripheral blood progenitor cells for hematopoietic stem cell transplantation.

1. Patients who are allergic to PEG-rhG-CSF, rhG-CSF and other preparations expressed by E. coli are contraindicated. Patients with severe liver, kidney, heart and lung dysfunction are contraindicated. 2. Pregnant and lactating women should use with caution.

Precautions during pregnancy and lactation: Use with caution in pregnant and lactating women.

3.0mg(1.0ml)/vial

CSPC Baike (Shandong) Bio-Pharmaceutical Co., Ltd.

• Founded in:

  1994-01-21

• Address:

  No. 212, Jinbu Street, Qinshui Korean Industrial Park, Muping District, Yantai City, Shandong Province

• Tax NO.:

  91370612613203660U

• Registered Funds:

  734.7 million yuan

• Website:

  Log in to view

• Email:

  Log in to view